Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • FLXTech
    Member
    • May 2008
    • 10

    #1

    GS FLX & Illumina

    Hi guys,

    I'm new to nextgen sequencing technologies. We have started using 454/FLX technology. Can anyone tell me how Illumina differs from FLX? Is it possible to sequence samples enriched on Agilent (sureselect) by FLX.
    Any thoughts appreciated.
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    Illumina and solid both take DNA fragments, and rather than giving you a few hundred bases, like 454 does, it gives you about 50 bases of each end, and it gives you a whole lot more of them. 10-20 million per lane, 8 lanes a run. If you have enough fragments, then having an idea of the distance between your two ends is almost as good as having the whole sequence.

    I don't see why Agilent wouldn't work with 454, but Roche owns Nimblegen, so they will steer you towards that technology, and not Agilent's. And that means that Agilent has a lot more incentive to work with Solid and Illumina, so you might not get as much support from Agilent as illumina users would.

    Comment

    • FLXTech
      Member
      • May 2008
      • 10

      #3
      Illumina

      Thanks for the reply, swbarnes2. I'm interested to know more about Illumina's work flow. Is it available on the web?

      Comment

      • joa_ds
        Member
        • Dec 2008
        • 52

        #4
        http://www.illumina.com will help you.

        Comment

        • FLXTech
          Member
          • May 2008
          • 10

          #5
          Thanks, joa_ds

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          44 views
          0 reactions
          Last Post SEQadmin2  
          Working...